Clinical trial NCT01688505: Visit-to-Visit Variability in Blood Pressure as a Predictor of Poor Cognitive Function
Official title: Multicenter Retrospective Study of Visit-to-Visit Variability in Blood Pressure as a Predictor of Poor Cognitive Function
Study type: OBSERVATIONAL
Overall status: UNKNOWN
Conditions: Cerebral Small Vessel Diseases
Keywords: cerebral small vessel diseases
cognitive impairment
Blood pressure variability
Lead sponsor: Hallym University Medical Center
Sponsor class: OTHER
First posted: 2012-09-20
Enrollment: 140
Sex: ALL
Minimum age (years): 60
Maximum age (years): 80
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: COHORT
Time perspective: RETROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Outpatients of stroke clinic in secondary or tertiary hospitals

Brief summary: Hypertension in midlife is an independent risk factor of late life cognitive dysfunction or dementia. Chronic hypertension cause vascular damage and cerebral ischemia, which ultimately gives rise to the cognitive dysfunction or dementia.

A recent study showed that high visit-to-visit variability in clinic systolic blood pressure (BP) was a strong independent predictor of stroke. This finding suggests that high clinic systolic BP variability itself as well as chronic hypertension may cause vascular damage and cerebral ischemia. Therefore, high clinic SBP variability may be also an independent risk factor of cognitive dysfunction or dementia.

Vascular damage leads to the diminished autoregulatory capacities of cerebral arteries. The brain with the reduced autoregulatory capacity may be more vulnerable to BP fluctuation. Therefore, high BP variability may be more harmful in patients with damaged vessels (for example, in patients with cerebral small vessel disease).

Previous data about BP variability and cognition revealed very controversial. Some studies showed poor cognition in patients with high BP variability, but others did not.

The previous studies were mostly based on cross-sectional designs, and performed in small-sized heterogeneous population for primary prevention. The harmful effect of high BP variability may be clearer in the population with damaged vascular bed, such as cerebral small vessel disease. The previous studies usually used ambulatory BP monitoring (ABPM). However, recent data suggested that variability in BP on ABPM may be a weaker predictor of vascular events than be visit-to-visit variability in clinic BP.

The investigators sought to find whether high visit-to-visit variability in clinic BP is related with poor cognitive function in patients with cerebral small vessel disease.

Detailed description: This is a retrospective cohort study.

We include patients with cerebral small vessel disease, documented on MRI from Jan 2006 to Dec 2010, who have been regularly followed up.

We evaluate the patients' cognitive function after written informed consent.

We independently review patients' medical record and analyze MRI data. BP variability parameters include standard deviation(SD, primary measuring parameter), coefficient of variation, successive variation, average real variability (ARV), SD independent of mean(SDIM), SV independent of mean(SVIM), and ARV independent of mean (ARVIM). We will adjust following confounding variables: age, sex, level of education, vascular risk factors, mean SBP and DBP, NIHSS score, and white matter lesion burden on T2-weighted MRI.

Eligibility criteria: Inclusion Criteria:

* Patients with cerebral small vessel disease previously documented on MRI (definition of small vessel disease - symptomatic lacunar infarction or white matter ischemic lesion with one or more asymptomatic lacunes)

Exclusion Criteria:

* Incomplete clinic BP data (less than 6 BP readings during recent one year)
* History of cardiovascular or cerebrovascular events during recent one year
* Documented cerebral infarction from large artery atherosclerosis
* Atrial fibrillation or cardiac disease with high risk of embolism
* Significant medical, neurological, or psychiatric disease affecting cognition
* Known dementia treated with acetylcholine esterase inhibitor or memantine
* Patients without informed consent

Primary outcomes:
measure: Association between raw score of K-MMSE and visit-to-visit systolic BP variability
timeFrame: Time from previous MRI documentation as small vessel disease to cognitive function evaluation; 1.5 to 7 years
Secondary outcomes:
measure: Association between raw score of K-MMSE and visit-to-visit diastolic BP variability
timeFrame: Time from previous MRI documentation as small vessel disease to cognitive function evaluation; 1.5 to 7 years
measure: Association between raw scores of "K-VCI NP 30-minute protocol" sub-tests and visit-to-visit systolic BP variability
timeFrame: Time from previous MRI documentation as small vessel disease to cognitive function evaluation; 1.5 to 7 years
measure: Association between raw scores of "K-VCI NP 30-minute protocol" sub-tests and visit-to-visit diastolic BP variability
timeFrame: Time from previous MRI documentation as small vessel disease to cognitive function evaluation; 1.5 to 7 years
Other outcomes:
Locations:
city: Chuncheon-si
country: Korea, Republic of
facility: Chuncheon Sacred Heart Hospital, Hallym University, College of Medicine
state: Gangwon-do
city: Anyang-si
country: Korea, Republic of
facility: Hallym University Sacred Heart Hospital, Hallym University, College of Medicine
state: Gyeonggi-do
city: Seoul
country: Korea, Republic of
facility: Gangdong Sacred Heart Hospital, Hallym University, College of Medicine
city: Seoul
country: Korea, Republic of
facility: Hangang Sacred Heart Hospital, Hallym University, College of Medicine
city: Seoul
country: Korea, Republic of
facility: Gangnam Sacred Heart Hospital, Hallym University, College of Medicine
Study officials:
References: